| EP0007450A1
              (de)
            
            * | 1978-07-07 | 1980-02-06 | Ciba-Geigy Ag | Azatetracyclische Carbonitrile, ihre Herstellung, pharmazeutische Präparate, die diese enthalten und deren Verwendung | 
        
          | ATE9159T1
              (de)
            
            * | 1979-12-10 | 1984-09-15 | Ciba-Geigy Ag | Azatetracyclische carbonitrile. | 
        
          | FR2504140A1
              (fr)
            
            * | 1981-04-16 | 1982-10-22 | Centre Nat Rech Scient | Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant | 
        
          | CA1202970A
              (en)
            
            * | 1982-05-18 | 1986-04-08 | Eugene J. Trybulski | Benzazepine derivatives | 
        
          | JPS62101941U
              (en:Method)
            
            * | 1985-12-16 | 1987-06-29 |  |  | 
        
          | IE62754B1
              (en)
            
            * | 1988-08-26 | 1995-02-22 | Akzo Nv | Tetracyclic antidepressants | 
        
          | EP0569096A1
              (en)
            
            * | 1992-05-08 | 1993-11-10 | Akzo Nobel N.V. | Depot preparation | 
        
          | WO1994022858A1
              (en)
            
            * | 1993-04-06 | 1994-10-13 | Abbott Laboratories | Tetracyclic compounds as dopamine agonists | 
        
          | JP4099224B2
              (ja)
            
            * | 1994-03-02 | 2008-06-11 | ナームローゼ・フエンノートチヤツプ・オルガノン | 舌下又はバッカル医薬組成物 | 
        
          | JP3274579B2
              (ja)
            
            * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 | 
        
          | CZ288865B6
              (cs)
            
            * | 1996-04-12 | 2001-09-12 | Janssen Pharmaceutica N. V. | Substituované tetracyklické deriváty tetrahydrofuranu, způsob jejich výroby, kompozice obsahující tyto deriváty a použití těchto derivátů jako léčiva | 
        
          | BR9809162A
              (pt)
            
            * | 1997-05-26 | 2000-08-01 | Akzo Nobel Nv | Sal de trans-5-cloro-2, 3, 3a, 12b-tetrahidro-2-metil-1h-dibenz [2,3:6,7] oxepino[4,5-c] pirrol e agente formador de sal, composto, composição farmacêutica, e, preparação de injeção armazenável | 
        
          | HRP20020305A8
              (en)
            
            * | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof | 
        
          | HRP20020441A2
              (en)
            
            * | 2002-05-21 | 2003-12-31 | Pliva D D | 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof | 
        
          | HRP20030160A2
              (en)
            
            * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof | 
        
          | EP1633400A2
              (en)
            
            * | 2003-05-16 | 2006-03-15 | Pfizer Products Inc. | Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines | 
        
          | HRP20030885A2
              (en)
            
            * | 2003-11-03 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS | 
        
          | HRP20030959A2
              (en:Method)
            
            * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. |  | 
        
          | HRP20030955A2
              (en)
            
            * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | 
        
          | HRP20030958A2
              (en)
            
            * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | 
        
          | HRP20030957A2
              (en)
            
            * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | 
        
          | HRP20030953A2
              (en)
            
            * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | 
        
          | HRP20030954A2
              (en)
            
            * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | 
        
          | HRP20030956A2
              (en)
            
            * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU | 
        
          | HRP20040104A2
              (en)
            
            * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders | 
        
          | RU2006129307A
              (ru)
            
            * | 2004-02-13 | 2008-02-20 | Пфайзер Продактс Инк. (Us) | Терапевтические комбинации атипичных нейролептиков с антагонистами кортикотропин-рилизинг фактора | 
        
          | JP2007537232A
              (ja)
            
            * | 2004-05-11 | 2007-12-20 | ファイザー・プロダクツ・インク | 非定型抗精神病薬と5−ht1b受容体拮抗薬の組合せ | 
        
          | CA2581188A1
              (en)
            
            * | 2004-10-15 | 2006-04-20 | Pfizer Inc. | Treatment of bipolar disorders and associated symptoms | 
        
          | US7872147B2
              (en) | 2005-04-07 | 2011-01-18 | N. V. Organon | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole | 
        
          | RS50532B
              (sr)
            
            * | 2005-04-07 | 2010-05-07 | N.V. Organon | Kristalni oblik azenapin maleata | 
        
          | TW200716589A
              (en)
            
            * | 2005-04-07 | 2007-05-01 | Organon Ireland Ltd | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole | 
        
          | US7741358B2
              (en)
            
            * | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate | 
        
          | WO2007046554A1
              (ja)
            
            * | 2005-10-21 | 2007-04-26 | Sumitomo Chemical Company, Limited | ジベンゾオキセピノピロール化合物の製造方法、その中間体及び該中間体の製造方法 | 
        
          | US7750167B2
              (en)
            
            * | 2006-07-05 | 2010-07-06 | N.V. Organon | Process for the preparation of asenapine and intermediate products used in said process | 
        
          | TW200817414A
              (en)
            
            * | 2006-07-05 | 2008-04-16 | Organon Nv | Process for the preparation of asenapine and intermediate products used in said process | 
        
          | TW200831514A
              (en)
            
            * | 2006-10-06 | 2008-08-01 | Organon Nv | Amorphous asenapine and processes for preparing same | 
        
          | US7875729B2
              (en)
            
            * | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine | 
        
          | EP2170399A1
              (en)
            
            * | 2007-06-05 | 2010-04-07 | Synthon B.V. | Intranasal administration of asenapine and pharmaceutical compositions therefor | 
        
          | JP5245428B2
              (ja)
            
            * | 2007-07-06 | 2013-07-24 | 住友化学株式会社 | トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体 | 
        
          | ATE527266T1
              (de)
            
            * | 2008-01-04 | 2011-10-15 | Organon Nv | Herstellungsverfahren für asenapin und in diesem verfahren verwendete zwischenprodukte | 
        
          | WO2009104080A2
              (en) | 2008-02-20 | 2009-08-27 | Targia Pharmaceuticals | Cns pharmaceutical compositions and methods of use | 
        
          | EP2321011A1
              (en)
            
            * | 2008-06-25 | 2011-05-18 | Pfizer Inc. | Diaryl compounds and uses thereof | 
        
          | RU2012102247A
              (ru)
            
            * | 2009-06-24 | 2013-07-27 | Мсд Осс Б.В. | Инъекционные композиции, содержащие асенапин и способ лечения с их применением | 
        
          | AR077429A1
              (es) | 2009-07-29 | 2011-08-24 | Organon Nv | Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos | 
        
          | CA2802990A1
              (en) | 2010-06-18 | 2011-12-22 | Dr. Reddy's Laboratories Ltd. | Asenapine maleate | 
        
          | EP2598496B1
              (en) | 2010-07-29 | 2014-03-19 | Laboratorios Lesvi, S.L. | Novel process for the preparation of asenapine | 
        
          | EA027840B1
              (ru) | 2010-11-15 | 2017-09-29 | Эйджинбайо, Инк. | Производные пиридазина, композиции и способы лечения когнитивного нарушения | 
        
          | WO2012066565A2
              (en) | 2010-11-16 | 2012-05-24 | Cadila Healthcare Limited | Asenapine maleate amorphous and crystalline form and process for preparation thereof | 
        
          | EP2468750A1
              (en) | 2010-12-13 | 2012-06-27 | Chemo Ibérica, S.A. | Polymorphic forms of asenapine maleate and processes for their preparation | 
        
          | ES2575544T3
              (es) | 2010-12-24 | 2016-06-29 | Medichem, S.A. | Procedimientos para la preparación de 5-cloro-2-metil-2,3,3a,12b-tetrahidro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pirrol | 
        
          | WO2012123325A1
              (en) | 2011-03-11 | 2012-09-20 | Medichem S.A. | NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID | 
        
          | EP2524921A1
              (en)
            
            * | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel Crystalline Salts of Asenapine | 
        
          | EP2524919A1
              (en)
            
            * | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids | 
        
          | WO2012156676A1
              (en) | 2011-05-18 | 2012-11-22 | Laboratorios Lesvi S.L. | Monoclinic crystalline form of asenapine maleate with a specific particle size distribution | 
        
          | ES2665843T3
              (es) | 2011-05-18 | 2018-04-27 | Laboratorios Lesvi, S.L. | Síntesis de una forma de maleato de asenapina monoclínica micronizada estable | 
        
          | WO2013024492A2
              (en) | 2011-07-01 | 2013-02-21 | Megafine Pharma (P) Ltd. | A process for the preparation of asenapine and novel salts thereof | 
        
          | WO2013011461A1
              (en) | 2011-07-20 | 2013-01-24 | Ranbaxy Laboratories Limited | Process for the preparation of asenapine maleate | 
        
          | WO2013035109A1
              (en) | 2011-09-08 | 2013-03-14 | Mylan Laboratories Ltd | Improved process for the preparation of asenapine maleate | 
        
          | WO2013041604A1
              (en) | 2011-09-21 | 2013-03-28 | Sandoz Ag | Crystal form of asenapine maleate | 
        
          | EP2572703A1
              (en) | 2011-09-21 | 2013-03-27 | Hexal AG | Compressed oral dosage form for asenapine maleate | 
        
          | WO2013080069A1
              (en) | 2011-11-28 | 2013-06-06 | Ranbaxy Laboratories Limited | Process for the preparation of asenapine intermediate | 
        
          | CN103254201B
              (zh)
            
            * | 2012-02-21 | 2016-04-13 | 四川科伦药物研究有限公司 | 一种阿塞那平的制备方法 | 
        
          | WO2013190481A1
              (en)
            
            * | 2012-06-21 | 2013-12-27 | Alembic Pharmaceuticals Limited | Process for preparing asenapine and salts of intermediates thereof | 
        
          | ITMI20121810A1
              (it) | 2012-10-24 | 2014-04-25 | Chemo Iberica Sa | Poliformi di maleato di asenapina e processo per la loro preparazione | 
        
          | US20140206667A1
              (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia | 
        
          | WO2014127786A1
              (en) | 2013-02-22 | 2014-08-28 | Zentiva, K.S. | Orally disintegrating pharmaceutical composition comprising asenapine | 
        
          | CN103113379A
              (zh)
            
            * | 2013-03-12 | 2013-05-22 | 盛世泰科生物医药技术(苏州)有限公司 | 阿塞那平马来酸盐的合成工艺 | 
        
          | CN103351393B
              (zh)
            
            * | 2013-07-03 | 2016-04-06 | 华裕(无锡)制药有限公司 | 用于制备阿森那平之还原剂及阿森那平之制备方法 | 
        
          | MX391314B
              (es) | 2013-12-20 | 2025-03-21 | Agenebio Inc | Derivados de benzodiazepina, composiciones, y metodos para tratar el deterioro cognitivo. | 
        
          | CN103772401A
              (zh)
            
            * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 11-氯-2,3,3a,12b-四氢-2-甲基-1H-二苯并[2,3:6,7]氧杂卓并[4,5-c]吡咯-1-酮的一种新精制方法 | 
        
          | CN103772400A
              (zh)
            
            * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 反式-5-氯-2,3,3a,12b-四氢-1H-二苯并[2,3:6,7]氧杂卓并[4,5-c]吡咯的制备方法 | 
        
          | US11154510B2
              (en) | 2015-06-11 | 2021-10-26 | Alrise Biosystems Gmbh | Process for the preparation of drug loaded microparticles | 
        
          | MX392119B
              (es) | 2015-06-19 | 2025-03-11 | Agenebio Inc | Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo | 
        
          | US11505555B2
              (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | 
        
          | US20180170941A1
              (en) | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | 
        
          | CA3047354A1
              (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene | 
        
          | PL3338768T3
              (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę | 
        
          | EP3644973B1
              (en) | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer | 
        
          | EA202190076A1
              (ru) | 2018-06-19 | 2021-09-22 | Эйджинбайо, Инк. | Производные бензодиазепина, композиции и способы лечения когнитивных нарушений | 
        
          | PL3810100T3
              (pl) | 2018-06-20 | 2025-05-12 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę | 
        
          | CN112533593A
              (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 | 
        
          | CN110183457A
              (zh)
            
            * | 2019-06-27 | 2019-08-30 | 浙江天顺药业有限公司 | 一种阿塞那平及其制备方法 | 
        
          | CN112830931A
              (zh) | 2019-08-13 | 2021-05-25 | 浙江奥翔药业股份有限公司 | 制备阿塞那平的方法 | 
        
          | US11679407B2
              (en)
            
            * | 2020-06-26 | 2023-06-20 | Intel Corporation | Liquid metal thermal interface material application | 
        
          | WO2023006954A1
              (en) | 2021-07-30 | 2023-02-02 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Asenapine for use in cancer | 
        
          | CN120584115A
              (zh) | 2022-08-19 | 2025-09-02 | 艾吉因生物股份有限公司 | 苯并氮杂䓬衍生物、组合物和用于治疗认知损害的方法 |